Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2016-01-01 (10 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: PARIS (75015), Paris
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
GRANDE PHARMACIE DU 15 EME : revenue, balance sheet and financial ratios
GRANDE PHARMACIE DU 15 EME is a French company
founded 10 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in PARIS (75015),
this company of category PME
shows in 2023 a net income positive of 8 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - GRANDE PHARMACIE DU 15 EME (SIREN 820344752)
Indicator
2023
2022
2018
Revenue
N/C
N/C
N/C
Net income
8 068 €
485 611 €
357 577 €
EBITDA
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
Revenue and income statement
In 2023, GRANDE PHARMACIE DU 15 EME generates positive net income of 8 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2023: 358 k€ -> 8 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
8 068 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 279%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 24%. The balance between equity and debt is satisfactory.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
278.555%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
23.57%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution GRANDE PHARMACIE DU 15 EME
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2022
2023
Debt ratio
408.3
321.296
278.555
Financial autonomy
17.278
20.843
23.57
Repayment capacity
None
None
None
Cash flow / Revenue
None%
None%
None%
Sector positioning
Debt ratio
278.562023
2018
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Average
In 2023, the debt ratio of GRANDE PHARMACIE DU 15 EME (278.56) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
23.57%2023
2018
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Average
In 2023, the financial autonomy of GRANDE PHARMACIE DU 15 EME (23.6%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 211.21. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
211.213
Liquidity indicators evolution GRANDE PHARMACIE DU 15 EME
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2018
2022
2023
Liquidity ratio
178.082
254.413
211.213
Interest coverage
None
None
None
Sector positioning
Liquidity ratio
211.212023
2018
2022
2023
Q1: 135.25
Med: 189.78
Q3: 270.35
Good
In 2023, the liquidity ratio of GRANDE PHARMACIE DU 15 EME (211.21) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of GRANDE PHARMACIE DU 15 EME in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of GRANDE PHARMACIE DU 15 EME is estimated at
95 198 €
(range 57 894€ - 133 827€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
57k€95k€133k€
95 198 €Range: 57 894€ - 133 827€
NAF 5 année 2023
Valuation method used
Net Income Multiple
8 068 €
×
11.8x
=95 198 €
Range: 57 895€ - 133 827€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare GRANDE PHARMACIE DU 15 EME with other companies in the same sector:
Frequently asked questions about GRANDE PHARMACIE DU 15 EME
What is the revenue of GRANDE PHARMACIE DU 15 EME ?
The revenue of GRANDE PHARMACIE DU 15 EME is not publicly disclosed (confidential accounts filed with INPI).
Is GRANDE PHARMACIE DU 15 EME profitable?
Yes, GRANDE PHARMACIE DU 15 EME generated a net profit of 8 k€ in 2023.
Where is the headquarters of GRANDE PHARMACIE DU 15 EME ?
The headquarters of GRANDE PHARMACIE DU 15 EME is located in PARIS (75015), in the department Paris.
Where to find the tax return of GRANDE PHARMACIE DU 15 EME ?
The tax return of GRANDE PHARMACIE DU 15 EME is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does GRANDE PHARMACIE DU 15 EME operate?
GRANDE PHARMACIE DU 15 EME operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart